Feasibility and Safety of Percutaneous Device Closure of Patent Ductus Arteriosus in Preterm Neonates: Experience From a Single Center in Northern India.

IF 1.5 4区医学 Q2 PEDIATRICS

Indian pediatrics Pub Date : 2025-08-08 DOI:10.1007/s13312-025-00157-8

Satya Prakash, Akash Singhal, Deepika Kainth, Lamk Kadiyani, Anu Thukral, M Jeeva Sankar, Saurabh Kumar Gupta, Sivasubramanian Ramakrishnan, Ramesh Agarwal, Ankit Verma

{"title":"Feasibility and Safety of Percutaneous Device Closure of Patent Ductus Arteriosus in Preterm Neonates: Experience From a Single Center in Northern India.","authors":"Satya Prakash, Akash Singhal, Deepika Kainth, Lamk Kadiyani, Anu Thukral, M Jeeva Sankar, Saurabh Kumar Gupta, Sivasubramanian Ramakrishnan, Ramesh Agarwal, Ankit Verma","doi":"10.1007/s13312-025-00157-8","DOIUrl":null,"url":null,"abstract":"Objective: To report the feasibility and safety of percutaneous device closure of patent ductus arteriosus (PDA) in preterm neonates from a tertiary center in Northern India.Methods: A retrospective chart review of the clinical profile, nature of device used, and outcomes of inborn preterm neonates who underwent percutaneous device closure of PDA was conducted. The intervention was performed by experienced pediatric cardiologists using a transvenous approach under fluoroscopic guidance.Results: Ten neonates with median (Q1, Q3) gestation of 29 (27, 30) weeks underwent device (Piccolo device) closure at a median (Q1, Q3) age of 37 (27, 41) days. At the time of procedure, the median (Q1, Q3) weight of the infants was 1270 (1120, 1890) g and the median (Q1, Q3) PDA diameter was 3.0 (2.3, 3.0) mm. Successful PDA closure was achieved in nine neonates; six showed clinical improvement. No procedure-related death was observed.Conclusions: Percutaneous device closure of PDA in preterm neonates is safe and feasible.","PeriodicalId":13291,"journal":{"name":"Indian pediatrics","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13312-025-00157-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To report the feasibility and safety of percutaneous device closure of patent ductus arteriosus (PDA) in preterm neonates from a tertiary center in Northern India.

Methods: A retrospective chart review of the clinical profile, nature of device used, and outcomes of inborn preterm neonates who underwent percutaneous device closure of PDA was conducted. The intervention was performed by experienced pediatric cardiologists using a transvenous approach under fluoroscopic guidance.

Results: Ten neonates with median (Q1, Q3) gestation of 29 (27, 30) weeks underwent device (Piccolo device) closure at a median (Q1, Q3) age of 37 (27, 41) days. At the time of procedure, the median (Q1, Q3) weight of the infants was 1270 (1120, 1890) g and the median (Q1, Q3) PDA diameter was 3.0 (2.3, 3.0) mm. Successful PDA closure was achieved in nine neonates; six showed clinical improvement. No procedure-related death was observed.

Conclusions: Percutaneous device closure of PDA in preterm neonates is safe and feasible.

查看原文本刊更多论文

经皮装置关闭早产儿动脉导管未闭的可行性和安全性：来自印度北部单一中心的经验。

目的：报道印度北部某三级医疗中心早产儿经皮动脉导管未闭（PDA）闭合术的可行性和安全性。方法：回顾性回顾临床资料，使用的设备的性质，以及出生早产儿经皮装置关闭PDA的结果。干预由经验丰富的儿科心脏病专家在透视指导下使用经静脉入路进行。结果：10名中位（Q1, Q3）妊娠期为29（27,30）周的新生儿在中位（Q1, Q3）年龄为37（27,41）天时接受了装置（Piccolo装置）闭合。手术时，婴儿体重中位数（Q1, Q3）为1270 (1120,1890)g， PDA直径中位数（Q1, Q3）为3.0 (2.3,3.0)mm。9例新生儿成功关闭PDA；6例临床改善。未观察到手术相关死亡。结论：经皮装置封堵早产儿PDA是安全可行的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Indian pediatrics 医学-小儿科

CiteScore

3.30

自引率

8.70%

发文量

344

审稿时长

3-8 weeks

期刊介绍： The general objective of Indian Pediatrics is "To promote the science and practice of Pediatrics." An important guiding principle has been the simultaneous need to inform, educate and entertain the target audience. The specific key objectives are: -To publish original, relevant, well researched peer reviewed articles on issues related to child health. -To provide continuing education to support informed clinical decisions and research. -To foster responsible and balanced debate on controversial issues that affect child health, including non-clinical areas such as medical education, ethics, law, environment and economics. -To achieve the highest level of ethical medical journalism and to produce a publication that is timely, credible and enjoyable to read.